View the latest clinical trials, studies, data, and updates.
Pivotal study to evaluate the use of novel liquid embolic versus standard of care in treating malignant and benign hypervascular tumors.
The first adjustable, fully visible stent retriever shows superiority over conventional stent retrievers in a multicenter trial. The late-breaking results were recently presented at the International Stroke Conference and published online in the journal Stroke.
The study will assess the duration of response (DoR) and objective response rate (ORR) of SIR-Spheres.
Research draws from real-world data sources including electronic medical records.
NovaSight has announced that it is running a large, pivotal multi-center randomized controlled trial to assess the safety and effectiveness of an eye-tracking-based treatment for Amblyopia (Lazy Eye).
The study will rely on Sonde One, a research-based smartphone app, which quickly and objectively detects signs of respiratory symptoms such as chest pain, coughing, or shortness of breath through a six-second voice sample.